Disarming MRSA through mechanism-guided repurposing of FDA-approved drugs and clinically investigated compounds
Methicillin-resistant Staphylococcus aureus remains a major global health threat in healthcare and community settings. Repurposing drugs approved by the U.S. Food and Drug Administration can shorten early discovery timelines, but in vitro antibacterial activity alone does not establish clinical feasibility. This review...
Raja Mohd Fadhil Raja Abd Rahman, Jomel Vasquez, Saiful Effendi Syafruddin et al.
· Figshare · 0 citations